ODDB.org: Open Drug Database

Devatis AG - Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten

Swissmedic Registration	68472	Sequence	03
Product name	Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg)	Description	Tabletten
ATC-Classification	N04BA02	ATC-Description	Levodopa and Decarboxylase Inhibitor
Introduction of Sequence	01.12.2021

Composition

benserazidum 50 mg ut benserazidi hydrochloridum, levodopum 200 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.01035 mg.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Benserazide	50 mg
Levodopa	200 mg

BAG: Active Agent	Dose
Benserazide	50 mg
Levodopa	200 mg

Inactive agents		additional_information
(Rubrum)
Amylum Pregelificatum
Calcium Hydrogen Phosphate
Cellulosum Microcristallinum
Crospovidonum
E 172		color.
Ethylcellulosum
Magnesii Stearas
Mannitol
Natrii Docusas
Pro Compresso
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	30	6.13	15.90	B	SL	Yes
006	100	18.65	36.70	B	SL	Yes

2025	©ywesee GmbH